Norveška -
norveški -
Statens legemiddelverk
vival 5 mg
actavis group ptc ehf (1) - diazepam - tablett - 5 mg
Norveška -
norveški -
Statens legemiddelverk
vival 2 mg
actavis group ptc ehf (1) - diazepam - tablett - 2 mg
Norveška -
norveški -
Statens legemiddelverk
mykofenolsyre accord 180 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 180 mg
Norveška -
norveški -
Statens legemiddelverk
mykofenolsyre accord 360 mg
accord healthcare b.v. - mykofenolatnatrium - enterotablett - 360 mg
Norveška -
norveški -
Statens legemiddelverk
stesolid 5 mg/2.5 ml
orifarm as - diazepam - rektalvæske, oppløsning - 5 mg/2.5 ml
Norveška -
norveški -
Statens legemiddelverk
tetmodis 25 mg
aop orphan pharmaceuticals gmbh - tetrabenazin - tablett - 25 mg
Europska Unija -
norveški -
EMA (European Medicines Agency)
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinuri, paroksysmal - immunsuppressive - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
Europska Unija -
norveški -
EMA (European Medicines Agency)
bekemv
amgen technology (ireland) uc - eculizumab - hemoglobinuri, paroksysmal - immunsuppressive - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dokumentasjon av klinisk nytte er vist hos pasienter med haemolysis med kliniske symptom(s) en indikasjon på høy sykdomsaktivitet, uavhengig av transfusjon historie (se punkt 5..
Norveška -
norveški -
Statens legemiddelverk
rativor 1 mg
macure healthcare limited - lorazepam - tablett - 1 mg
Norveška -
norveški -
Statens legemiddelverk
rativor 0.5 mg
macure healthcare limited - lorazepam - tablett - 0.5 mg